Fellowship · Rochester, NY
Sponsored by University of Rochester Medicine
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
American journal of respiratory and critical care medicine · 2022 · 2,358 citations · Manoj J. Mammen
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
The New England journal of medicine · 2021 · 1,044 citations · Joseph Boscia
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA · 2021 · 739 citations · Joseph Boscia
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
American journal of respiratory and critical care medicine · 2025 · 112 citations · Manoj J. Mammen
Biologics in severe asthma: a state-of-the-art review.
European respiratory review : an official journal of the European Respiratory Society · 2025 · 87 citations · Bishal Gyawali, Steve N. Georas, Sandhya Khurana
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
The New England journal of medicine · 2021 · 533 citations · Joseph Boscia
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
Critical care medicine · 2021 · 299 citations · Manoj J. Mammen
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination.
Nature medicine · 2025 · 71 citations · Frances Lee